Basic Information
Basic information for SOX2-OT-234-12aa-3
Peptide Name SOX2-OT-234-12aa-3
Genome Position chr3:181740784-181740819[+]
Species Human
Peptide Sequence MAFLALKFITLK
Peptide Length 12
Unique No (SOX2-OT-203-12aa,SOX2-OT-207-12aa-3,SOX2-OT-213-12aa,SOX2-OT-218-12aa-1,SOX2-OT-225-12aa-3,SOX2-OT-231-12aa,SOX2-OT-249-12aa,SOX2-OT-261-12aa,SOX2-OT-268-12aa,SOX2-OT-272-12aa,SOX2-OT-276-12aa-3,SOX2-OT-280-12aa,SOX2-OT-283-12aa-3,SOX2-OT-285-12aa-3,SOX2-OT-287-12aa-3,SOX2-OT-291-12aa-3,SOX2-OT-292-12aa-3,SOX2-OT-293-12aa-3,SOX2-OT-294-12aa-1,SOX2-OT-295-12aa-3,SOX2-OT-296-12aa-3,SOX2-OT-297-12aa-3,SOX2-OT-298-12aa-1,SOX2-OT-299-12aa-3,SOX2-OT-300-12aa,SOX2-OT-301-12aa,SOX2-OT-303-12aa-1,SOX2-OT-304-12aa-1)
Grand Average of Hydropathicity 1.5417
Relative Molecular Mass 1593.99
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000242808;SOX2-OT
Transcript ID/Name ENST00000600801;SOX2-OT-234
Transcript Length 4085
Coding Ability 0.2835
DNA Sequence Corresponding to Peptide ATGGCTTTTTTAGCTTTAAAGTTCATTACTCTAAAA
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :